Charles River Laboratories International CRL
NYSE CRL
$302.62 +3.60 (+1.20%)
As of: Oct 14, 2026 · 3:07 PM EDT

Charles River Laboratories International (CRL) EBT Margin (2009 - 2026)

Updated

Charles River Laboratories International (CRL) posted EBT Margin of 5.30% for Q2 2026, down 1.62 percentage points from 6.92% a year earlier but up 8.30 percentage points from the prior quarter.

Analysis

Charles River Laboratories International (CRL) EBT Margin (2009 - 2026) Analysis & Trends

For the trailing twelve months through Jun 27, 2026, EBT Margin at Charles River Laboratories International was -4.59%, down 4.14 percentage points year-over-year; for FY2025, it came in at -2.48%, down 4.78 percentage points from FY2024.

  • Annual EBT Margin has declined for three consecutive years, with a five-year change of -17.77 percentage points (FY2020 to FY2025).
  • In prior years, Charles River Laboratories International's EBT Margin was 2.30% in FY2024 (-11.78 pp), 14.08% in FY2023 (-1.59 pp), 15.67% in FY2022 (+2.09 pp) and 13.58% in FY2021 (-1.71 pp).
  • Quarterly EBT Margin has run from a low of -29.58% in Q4 2025 to a high of 22.27% in Q4 2022 over five years.
  • On a year-over-year basis, EBT Margin has declined in each of the last 13 quarters, with an average year-over-year change of -8.96 percentage points over the last eight quarters.
  • The strongest year-over-year quarter for EBT Margin in the past five years was Q4 2022, with a gain of 4.19 percentage points; the weakest was Q4 2024, with a drop of 42.22 percentage points.
  • According to Business Quant data, EBT Margin for the three prior quarters was -3.01% (Q1 2026), -29.58% (Q4 2025) and 8.68% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin (Qtr)
1 Iqvia Holdings 43.47 Bn 35.18 Bn 1.44 Bn 6.89%
2 Medpace Holdings 17.38 Bn 15.44 Bn 201.64 Mn 21.44%
3 Charles River Laboratories International 14.51 Bn 13.70 Bn 363.37 Mn 5.30%
4 Icon 13.19 Bn 10.30 Bn 479.29 Mn 4.47%
5 Fortrea Holdings 2.02 Bn 1.39 Bn 139.20 Mn -0.18%
6 Ginkgo Bioworks Holdings 711.74 Mn -50.34 Mn 18.44 Mn -283.75%
7 Evotec SE 504.32 Mn -1.11 Bn - -
8 Champions Oncology 66.57 Mn 41.65 Mn 7.70 Mn -2.72%
9 MindWalk Holdings 64.47 Mn 28.12 Mn 1.61 Mn -154.59%
10 Natural Alternatives International 6.84 Mn -21.24 Mn 1.73 Mn -39.10%
Historic Data

Historic Data

Download Data
DateValue
Jun 27, 2026 5.30%
Mar 28, 2026 -3.01%
Dec 27, 2025 -29.58%
Sep 27, 2025 8.68%
Jun 28, 2025 6.92%
Mar 29, 2025 3.66%
Dec 28, 2024 -21.62%
Sep 28, 2024 9.04%
Jun 29, 2024 11.66%
Mar 30, 2024 9.79%
Dec 30, 2023 20.59%
Sep 30, 2023 10.99%
Jul 1, 2023 12.14%
Apr 1, 2023 12.73%
Dec 31, 2022 22.27%
Sep 24, 2022 12.45%
Jun 25, 2022 14.81%
Mar 26, 2022 12.13%
Dec 25, 2021 18.08%
Sep 25, 2021 13.76%
API Access

Charles River Laboratories International EBT Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebt-margin&ticker=CRL&period=max&api_key=YOUR_API_KEY